Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class small molecule product candidates with broad potential benefit to patients
Science
Modulating validated and new pathways to develop novel therapeutics
News
January 7, 2021
Tempest Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 8, 2021
Tempest Therapeutics to Present at the H.C. Wainwright Virtual Bioconnect Conference
Events
39th Annual J.P. Morgan Healthcare Conference
Thursday, January 14, 2021 at 2:00 pm Eastern Time
H.C. Wainwright Virtual BioConnect Conference
Monday, January 11, 2021 at 6:00 am Eastern Time